Intravitreal Anti-VEGF Therapy May Carry Small But Significant Intraocular Inflammation Risk

Thursday, June 17, 2010

Ocular Surgery News

Intravitreal injection of anti-VEGF therapeutics may result in potentially vision-damaging intraocular inflammation, according to a study.

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

AdGlare Leaderboard